Marginal Dialysis: Patient characteristics influencing outcomes
|
|
- Catherine Eaton
- 6 years ago
- Views:
Transcription
1 Marginal Dialysis: Patient characteristics influencing outcomes Dr Celine Foote Staff specialist, Concord Repatriation General Hospital Post-Doctoral Research Fellow, The George Institute for Global Health
2 Outline Description of marginal dialysis patients Characteristics which influence their outcomes Comorbid burden Cognitive function Frailty Malnutrition Use of risk prediction tools to put these characteristics together
3 We are dialysing large numbers of older patients but this has levelled off in last 5yrs In 2015, 19% of pts (n=513) starting dialysis in Australia were aged 75 New patients per million population New patients Age specific rates - Australia Age ANZDATA Annual Report, Figure 1.3 ANZDATA report 2016 New patients per million population New patients Age specific rates - New Zealand Age ANZDATA Annual Report, Figure 1.3
4 Older patients have substantial comorbid burden Foote et al. NDT 2012
5 High comorbid burden especially DM but falling prevalence of other conditions 60 Diabetes status at RRT entry Australia New Zealand % of patients Non-diabetic Type 1 diabetes Type 2 diabetes 2016 ANZDATA Annual Report, Figure Comorbid conditions at RRT entry Australia Suspected cases included 2016 ANZDATA Annual Report, Figure 1.8 % of patients Coronary Peripheral vascular Lung Cerebrovascular Comorbid conditions at RRT entry New Zealand Suspected cases included 2016 ANZDATA Annual Report, Figure 1.8 Coronary Peripheral vascular Lung Cerebrovascular ANZDATA report 2016
6 In my unit we have used dialysis to treat patients with these characteristics: Patients > 90years old Strongly agree Agree Neutral Disagree Strongly disagree Bed bound patients Foote et al, unpublished data 0 Strongly agree Agree Neutral Disagree Strongly disagree
7 In my unit we have used dialysis to treat patients with these characteristics: 40 Patients with <1 year life expectancy strongly agree agree neutral disagree strongly disagree Foote et al, unpublished data
8 In my unit we have used dialysis to treat patients with these characteristics: Nursing home residents Strongly agree Agree Neutral Disagree Strongly disagree Severely demented patients Foote et al, unpublished data Strongly agree Agree Neutral Disagree Strongly disagree
9 Survival of older dialysis patients is worse than most common cancers prostate cancer 92% breast cancer 89% renal cancer 72% bowel cancer 66% dialysis in Australia aged % Heart failure 52% ovarian cancer 43% dialysis in Australia aged % aged % lung cancer < 14% 5 year survival data from the Cancer Council of Australia ( and ANZDATA 2012 ( JAMA. 2004; 292(3):344.
10 How long older dialysis patients survive is affected by comorbid burden ANZDATA report 2015
11 Dialysis start also impacts on function, cognition and QOL of older patients Older patients have higher risk of functional 1 and cognitive loss 2 and often also have decline in QOL 3 following dialysis commencement 1. Jassal et al, NEJM Murray et al, Neurology Da Silva-Gane et al, CJASN 2012
12 Comorbid burden
13 Higher comorbid score* predicts poorer survival or more Followup (years) Comorbid score HR 95%CI P value < < <0.001 * Includes coronary heart disease, peripheral vascular disease, cerebrovascular disease, chronic lung disease and diabetes Foote et al. NDT 2012
14 There may be no survival advantage with dialysis with increasing comorbidity Murtagh et al. NDT 2007
15 There may be no survival advantage with dialysis with increasing comorbidity Brown et al. CJASN, 2015
16 Cognitive function
17 Mild cognitive impairment is a common but poorly recognized problem 16-38% cognitive impairment in all dialysis pts 1 68% in those aged over 75 2 Documented in only 3% 3 Uncertainty remains as to which cognitive instrument to use 1. KurellaTamura et al. KI Patel et al, HKJN Murray et al, Neurology 2006
18 Mild cognitive impairment leads to independent increased mortality risk Griva et al, AJKD 2010
19 Frailty
20 Frailty is common in CKD patients Prevalence of frailty in CKD population is twice that of general geriatric outpatient community 14% 15% versus 6% 7% 1,2 Prevalence increases markedly in dialysis population and with increasing age 44% in dialysis patients aged<40 and 78% in aged> Shlipak et al, AJKD Roshanravan et al, AJKD Johansen et al JASN 2007
21 Frailty leads to independent and graded increased mortality risk Independent 2.24x increased risk of death 1 Also 1.63x risk of death or hospitalization 1 Risk is graded with each 1-point increase in frailty associated with 1.22x increased risk of death 2 1. Johansen et al JASN Alfaadhel et al, CJASN 2015
22 Frailty has substantial impact on life expectancy Swidler CJASN 2013
23 Malnutrition
24 Malnutrition predicts increased mortality risk but may be poorly characterised Malnutrition prevalence varies between 18%-75% in dialysis patients 1 Older patients are at increased risk 2 Albumin is commonly used as a surrogate Predictor of mortality in general 3 and older dialysis patients 4 but some inconsistency in literature 5 Confounded by inflammation and comorbidity 6 1. Kalantar-Zadeh et al, AJKD Qureshi et al, KI Iseki et al, KI Oliva et al, J Nephrol Chan et al, J of Renal Nutrition Stenvinkel et al, NDT 2002
25 7 point SGA is a better predictor of malnutrition and predicts mortality in pts starting dialysis 7 point Subjective Global Assessment (SGA) is a better predictor of malnutrition Not confounded by inflammation or obesity 1 SGA score is independently associated with mortality in incident dialysis pts 2 Predictive capacity in older dialysis patients 3 1. Chan et al, J of Renal Nutrition De Mutsert et al, Am J Clin Nutr Santin et al, Clin Nutr in press
26 Risk prediction tools
27 Risk tool combining comorbidity, albumin and SQ is useful in predicting prognosis in the general HD population Cohen et al et al. CJASN 2010
28
29 Several risk tools are available for older dialysis patients but have limitations Four prediction tools derived in older dialysis pts Derived from French renal registry 1,2, US Medicare 3 and Albertan databases 4 Risk factors assessed are dictated by availability Heart failure, arrhythmia and malignancy were consistent predictors Limited assessment of cognition, functional status Lack of clinical judgment assessment like SQ Only predict short term dialysis survival (3-6 month) 1. Couchoud et al. NDT Couchoud et al, NDT Thamer et al, AJKD Wick et al, AJKD in press
30 Summary Large numbers of older patients with considerable comorbid burden Patient characteristics which influence outcomes include: Comorbid burden Cognitive function Frailty Malnutrition Use of risk prediction tools can assist in prognostication for individual patients
31 Suggestions for next steps. Systematic collection in all older pts approaching ESKD of presence of: Cognitive function Frailty Malnutrition Irrespective of planned treatment pathway Improve prognostication for appropriate use of resources
32 Thank you for your attention
33 Do you systematically test cognitive function on older patients approaching treatment decisions for ESKD? 1. Yes 2. No 3. Uncertain
34 Should a diagnosis of dementia be a contraindication to dialysis? 1. Yes 2. No 3. Uncertain
35 Do you formally assess for frailty in older patients approaching treatment decisions for ESKD? 1. Yes 2. No 3. Uncertain
36 How do you assess for frailty? 1. Fried s criteria 2. Frailty index 3. FRAIL 4. Clinical frailty scale 5. Physician perception 6. Uncertain
37 There are many different ways to measure frailty 1) Physical frailty 2) Frailty index 3) FRAIL 4) Clinical frailty scale
38 Fried et al, J Gerontol A Biol Sci Med Sci 2001 Frailty assessments 1. Fried
39 Frailty assessments 2. Frailty index Number of deficits in an individual /Total number of deficits measured Based on accumulation of illnesses, functional and cognitive declines, and social situations It requires answering 20 or more medical and functional-related questions.
40 Frailty assessments 3. FRAIL Fatigue ("Are you fatigued?") Resistance ("Can you climb one flight of stairs?") Ambulation ("Can you walk one block?") Illnesses (greater than five) Loss of weight (greater than 5 percent) Morley JE et al., J Nutr Health Aging 2012
41 Rockwood et al, Can Med Assoc J 2005 Frailty assessments 4. Clinical Frailty Scale
42 Do you formally assess for malnutrition in older patients approaching treatment decisions for ESKD? 1. Yes 2. No 3. Uncertain
43 How do you assess malnutrition in your elderly ESKD patients? 1. Serum albumin 2. Body mass index 3. Anthropometry 4. Subjective Global Assessment 5. Uncertain
44
45
46
47
48 Do we need to capture comorbid burden? Which patients do we target? Which tool to use? Who does it formally (on top of ANZDATA)? How do we utilise the comorbid information?
49 New comorbidity index predicts survival in older dialysis patients Kan et al. Plos One 2013
50 There may be no survival advantage with dialysis with increasing comorbidity SC n=54, dialysis n=17 Chandna et al. NDT 2010
51 Cognitive impairment Need to screen? Who to screen? What tool to screen with? How to interpret finding of cognitive impairment into decision making? Should a diagnosis of dementia be a CI to dialysis
52 Cognitive impairment is a common but poorly recognized problem amongst older ESKD patients Dementia prevalence was 22% in elderly nursing home patients starting dialysis % cognitive impairment on neuropsychological testing in ESKD patients aged over 75 2 Uncertainty remains as to which cognitive instrument to use Multiple screening cognitive assessments exist No validation against clinical diagnoses of dementia in the ESKD population 3 Many are influenced by educational level and language fluency 1. Tamura et al. NEJM Tamura et al. CJASN Tamura et al. KI 2011
53 Dementia leads to increase mortality and dialysis withdrawal Dementia confers independent increased risk of death 1,2 2-yr survival for pts with dementia was 24% versus 66% for pts without dementia (P < 0.001) 2 Also increased dialysis withdrawal (RR 2.01, 95% CI ) 2 1.Kurella et al, NDT Rakowski et al, CJASN 2006
54 Frailty assessments Who to screen? What tool to screen with? How to interpret finding of frailty into decision making?
55 Frailty in dialysis patients leads to independent and graded increased mortality risk Independent 2.24x increased risk of death 1 Also found 1.63 risk of death or hospitalization 1 Each 1-point increase in frailty led to 1.22 increased risk of death 2 1. Johansen et al JASN Alfaadhel et al, CJASN 2015
56 7 point SGA 1. Weight loss 2. Dietary intake 3. GI symptoms (nausea/vomiting/diarrhoea) 4. Functional status (nutrition related) 5. Disease state affecting nutrition requirements 6. Muscle wastage 7. Fat stores 8. Oedema
57 Use of risk prediction tools Which tool? Use with limitations in mind Who uses these?
58 Surprise question (SQ)
59 SQ predicts increased mortality Would I be surprised if this patient died in the next year? Moss et al. CJASN 2008
60 Literature search and survey identified important factors and these were presented to nephrologists and advanced trainees
61
62 Respondents chose neither patient for 57.3% of the scenarios,
63
64 Cognition, patient choice and expected fall in QOL as most important attributes Furthermore looked at trade-offs: Nephrologists were willing to forgo 12 months of patient survival in order to avoid a substantial decrease in QOL following dialysis start Survival trade-off is similar to 15 months of life expectancy that patients were willing to give up to decrease their travel restrictions 1 1. Morton et al. CMAJ 2011
Outcomes of dialysis in the elderly. DNT March 2011 Dr Céline Foote
Outcomes of dialysis in the elderly DNT March 2011 Dr Céline Foote Increasing number of elderly patients on renal replacement therapy 500 500 Patients per million 400 300 200 100 400 300 200 100 TOTAL
More informationDialysis versus Supportive Care
Dialysis versus Supportive Care with a focus on the initial pathway in the elderly DNT Workshop. Glenelg, February 2017 Background: A better title would be dialysis v non-dialysis! For this discussion:
More informationMalnutrition in advanced CKD
Malnutrition in advanced CKD Malnutrition Lack of proper nutrition, caused by not having enough to eat, not eating enough of the right things or being unable to use the food that one does eat Jessica Stevenson
More informationGeriatric Nephrology. Murtener Tage
Geriatric Nephrology Murtener Tage 2014 Isabelle.Binet@kssg.ch www.nierenstiftung.ch Plan Geriatric nephrology The elderly with CKD The elderly on dialysis The elderly in transplantation Plan Geriatric
More informationManagement of the Frail Older Patients: What Are the Outcomes
Management of the Frail Older Patients: What Are the Outcomes Professor Edwina Brown Imperial College Renal and Transplant Centre Hammersmith Hospital, London Increasing prevalence of old old on RRT RRT
More informationA tale of two specialties
A tale of two specialties United Kingdom Annual Symposia on Renal-Palliative Care co-organised by both disciplines National Service Framework for Renal Services Part 2 (UK) - 2005 Concentrated on the
More informationWebEx Quick Reference
Session 2 Drs. Alvin Moss & David Weissman WebEx Quick Reference Welcome to today s session! Please use Chat to All Raise your hand Participants for questions For technology issues only, please Chat to
More informationRenal Supportive Care. Renal Supportive Care Symposium 2013 Elizabeth Josland CNC
Renal Supportive Care. Renal Supportive Care Symposium 2013 Elizabeth Josland CNC Outline Background of Renal Supportive Care Conservative Management Symptom overview Reading What does conservative management
More informationTreatment decision making for ESKD patients dialysis versus supportive care
Treatment decision making for ESKD patients dialysis versus supportive care Dr Céline Foote Staff specialist, Concord Repatriation General Hospital Research Fellow, The George Institute for Global Health
More informationChronic renal disease in the elderly: are all pigs to be considered equal?
Chronic renal disease in the elderly: are all pigs to be considered equal? W. Van Biesen, Ghent University Hospital Elwood et al, cjasn, 2013 Elderly and CKD: a thematic synthesis Overview CKD in the
More informationANZSN Renal Supportive Care Guidelines 2013
bs_bs_banner Nephrology 18 (2013) 401 454 Reviews ANZSN Renal Supportive Care Guidelines 2013 THE OFTEN DIFFICULT DECISION OF WHICH PATIENTS WILL BENEFIT FROM DIALYSIS Mark A Brown 1 and Susan M Crail
More informationPATIENTS WHO WITHDRAW FROM DIALYSIS. Dr Katalin Urban Palliative Care Specialist Greenwich Hospital
PATIENTS WHO WITHDRAW FROM DIALYSIS Dr Katalin Urban Palliative Care Specialist Greenwich Hospital Registrar project for FRACP Title: Patients who withdraw from dialysis in a Sydney centre with Palliative
More informationWHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington
WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have
More informationA team s approach to QOL in CKD patients
A team s approach to QOL in CKD patients Edwin Fong MD FRCPC Which Team? Beauty Symmetry Beauty defined Suntanned Narrower face Less fat Fuller lips Bigger distance of eyes Darker eye brows Higher cheek
More informationOld age, polymorbidity and stroke, a new epidemy?
Old age, polymorbidity and stroke, a new epidemy? Professor Gary Ford Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford University Hospitals Visiting Professor
More informationAcceptance onto dialysis guidelines: St George Hospital
Acceptance onto dialysis guidelines: St George Hospital The following information is a guideline to support clinicians in decision making regarding acceptance onto dialysis. A review of international guidelines
More informationSurvival comorbidity. Mrs Retha Steenkamp Senior Statistician UK Renal Registry. UK Renal Registry 2011 Annual Audit Meeting
Survival comorbidity Mrs Retha Steenkamp Senior Statistician UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting Importance of co-morbidities in survival Co-morbidities collected by the Renal
More informationThe Elderly Patient with Low egfr: Beyond a Disease-Oriented Approach. Maroun Azar, M.D.
The Elderly Patient with Low egfr: Beyond a Disease-Oriented Approach Maroun Azar, M.D. Disclosures None, no conflicts of interest Some of the Arguments Are current definitions of CKD accurate in the
More informationThe Conundrum of First Dialysis Modality in Diabetic Patients with ESKD
The Conundrum of First Dialysis Modality in Diabetic Patients with ESKD Davide Bolignano, MD FERA National Research Council (CNR)Institute of Clinical Physiology Reggio Calabria, Italy Worldwide prevalence
More information21th Budapest Nephrology School Ágnes Haris, Kálmán Polner
21th Budapest Nephrology School Ágnes Haris, Kálmán Polner 53 years old female, -worked as computer scientist, -lived with her husband and 2 children, -in excellent financial situation. Diagnosed with
More informationEnd stage renal disease and Protein Energy wasting
End stage renal disease and Protein Energy wasting Dr Goh Heong Keong MBBS,MRCP(UK) www.passpaces.com/kidney.htm Introduction Chronic kidney disease- increasing health burden in many countries. The estimated
More informationThe Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function)
The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function) Thomas A. Golper MD, FACP, FASN Vanderbilt University Medical Center
More informationEpidemiology, Diagnostic and treatment for Protein Energy Wasting in Dialysis
Epidemiology, Diagnostic and treatment for Protein Energy Wasting in Dialysis Pr Denis FOUQUE Department of Nephrology Centre de Recherche en Nutrition Humaine University Claude Bernard Lyon - France ESRD
More informationPalliative and End of Life Care in End Stage Renal Disease
Palliative and End of Life Care in End Stage Renal Disease Palliative and End of Life Care Priority for Action Regional Consensus Workshop 30.06.2010 Neal Morgan Consultant Nephrologist SHSCT Outline Introduction
More informationPalliative Care in Chronic Kidney Disease: Past Successes, Remaining Challenges. Sara Davison BC Nephrology Days, Vancouver, BC Nov 6, 2009
Palliative Care in Chronic Kidney Disease: Past Successes, Remaining Challenges Sara Davison BC Nephrology Days, Vancouver, BC Nov 6, 2009 Objectives Highlight the relevance of palliative/supportive care
More informationPr Denis FOUQUE. Department of Nephrology Centre de Recherche en Nutrition Humaine University Claude Bernard Lyon - France
Pr Denis FOUQUE Department of Nephrology Centre de Recherche en Nutrition Humaine University Claude Bernard Lyon - France Observatoire Phosphocalcique, January 2011 1200 36.1 ± 5.0 g/l 1050 900 PEW
More informationChapter 10. Cancer. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015
Chapter Cancer 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Incidence of Cancer on Renal Replacement Therapy Figures.1-.6 and table.1 show the cumulative incidence of non-skin cancer in patients
More informationHigh prevalence of frailty in end-stage renal disease Drost, Diederik; Kalf, Annette; Vogtlander, Nils; van Munster, Barbara C.
University of Groningen High prevalence of frailty in end-stage renal disease Drost, Diederik; Kalf, Annette; Vogtlander, Nils; van Munster, Barbara C. Published in: International urology and nephrology
More informationChapter 10. Cancer. ANZDATA gratefully acknowledges the contributions of the Cancer Working Group convened by Germaine Wong.
Chapter Cancer ANZDATA gratefully acknowledges the contributions of the Cancer Working Group convened by Germaine Wong Contents: Cancer -1 Incidence of Cancer on Renal Replacement Therapy -2 Kidney Cancer
More informationCaring for the AKI Survivor: What is Required?
Caring for the AKI Survivor: What is Required? Ron Wald, MDCM MPH FRCPC Division of Nephrology St. Michael s Hospital and University of Toronto February 28, 2019 A patient in your ICU 65M with DM, HTN,
More informationCHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand
CHAPTER 9 End Stage Kidney Disease in Aotearoa/New Zealand ANZDATA gratefully acknowledges the patients and their families and the clinicians who provided data, and the contributions of the Aotearoa/New
More informationTHE CONSERVATIVE CARE PATHWAY
THE CONSERVATIVE CARE PATHWAY Dr. Gaylene Hargrove Sept. 19, 2015 Island Health Renal Program End of Life Conference Learning Objectives Describe and discuss what defines conservative care. Identify key
More informationTransplant Options for Patients: Choices and Consequences. Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital
Transplant Options for Patients: Choices and Consequences Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital BC Kidney Days October 6 th 2017 Non contributory Conflict of
More informationData Linkage. Dr Sradha Kotwal DNT Adelaide, Staff Specialist, Department of Nephrology Prince of Wales Hospital, Randwick, Sydney
Data Linkage Dr Sradha Kotwal DNT Adelaide, 2017 Staff Specialist, Department of Nephrology Prince of Wales Hospital, Randwick, Sydney Post-Doctoral Research Fellow, The George Institute for Global Health,
More informationCOGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E
COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E Attention Problem Solving Language Cognitive Domains Decision Making Memory Reasoning The Cardiovascular Health Cognition Study shows higher S
More informationBiological theory for the construct of intrinsic capacity to be used in clinical settings Matteo Cesari, MD, PhD
Biological theory for the construct of intrinsic capacity to be used in clinical settings Matteo Cesari, MD, PhD World Health Organization Geneva (Switzerland) December 1, 2016 World Health Organization.
More informationPalliative care for advanced renal disease: A summary of the evidence and future direction
491796PMJ27910.1177/0269216313491796Palliative MedicineKane et al. 2013491796PMJ Special Article PALLIATIVE MEDICINE Palliative care for advanced renal disease: A summary of the evidence and future direction
More informationKidney Transplantation in the Elderly. Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo
Kidney Transplantation in the Elderly Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo Agenda Background: Age and chronic kidney disease End stage kidney disease:
More informationThe patient with multiple chronic conditions: balancing guidelines and patient preference
The patient with multiple chronic conditions: balancing guidelines and patient preference Sid Feldman MD CCFP FCFP Associate Professor, Department of Family and Community Medicine, University of Toronto
More informationCHAPTER 3 DEATHS. Stephen McDonald Leonie Excell Brian Livingston
CHAPTER 3 DEATHS Stephen McDonald Leonie Excell Brian Livingston DEATHS ANZDATA Registry 2008 Report INTRODUCTION AUSTRALIA NEW ZEALAND The total number of deaths was 1,452 (15.4 deaths per 100 patient
More informationChapter 2. Prevalence of End Stage Kidney Disease. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015
Chapter 2 Prevalence of End Stage Kidney Disease 2016 ANZDATA Registry 39th Annual Report Data to 31-Dec-2015 Renal Replacement Therapy Table 2.1 shows the prevalence (pmp) of renal replacement therapy
More informationObjectives At the end of the session, participants will be able to:
Living Well Without Dialysis Why Conservative Kidney Management? Dr. Sara Davison Professor of Medicine University of Alberta Director, Kidney Supportive Care Research Group Dr. Clare Gibson BSc, PhD Filmmaker,
More informationEnd Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand
Chapter 12 End Stage Kidney Disease Among Indigenous Peoples of and New Zealand 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, rates of end-stage kidney disease
More informationCHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease
CHAPTER 2 Prevalence of Renal Replacement Therapy for End Stage Kidney Disease Summarising the number of prevalent renal replacement therapy patients in Australia and New Zealand, the prevalence rate per
More informationSERVICE SPECIFICATION 6 Conservative Management & End of Life Care
SERVICE SPECIFICATION 6 Conservative Management & End of Life Care Table of Contents Page 1 Key Messages 2 2 Introduction & Background 2 3 Relevant Guidelines & Standards 2 4 Scope of Service 3 5 Interdependencies
More informationWhat Happened? 3/20/2017. Changing Lives and Making a Difference: Home Hemodialysis Stories. Brigitte Schiller, MD, FACP, FASN
Changing Lives and Making a Difference: Home Hemodialysis Stories Brigitte Schiller, MD, FACP, FASN Chief Medical Officer Satellite Healthcare What Happened? We started building centers We started peritoneal
More informationDialysis for everyone? Maurizio Gallieni
Dialysis for everyone? Maurizio Gallieni Nephrology and Dialysis Unit Ospedale S. Carlo Borromeo, ASST Santi Paolo e Carlo, University of Milano, Milano, Italy Introduction NDT 2004; 19: 1357-1360 www.
More informationPre-ESRD Changes in Body Weight and Survival in Nursing Home Residents Starting Dialysis
CJASN epress. Published on September 5, 2013 as doi: 10.2215/CJN.01410213 Article Pre-ESRD Changes in Body Weight and Survival in Nursing Home Residents Starting Dialysis Shobha Stack,* Glenn M. Chertow,*
More informationNutrition Assessment in CKD
Nutrition Assessment in CKD Shiaw-Wen Chien, MD, EMBA Division of Nephrology, Department of Medicine, Tungs Taichung MetroHarbor Hospital Taichung, Taiwan September 10, 2017 Outline Introduction Composite
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Other criteria for starting dialysis GUIDELINES
Date written: September 2004 Final submission: February 2005 Other criteria for starting dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationHIV, Multimorbidity, and Frailty: what s going on? (with apologies to Marvin Gaye)
HIV, Multimorbidity, and Frailty: what s going on? (with apologies to Marvin Gaye) Julian Falutz MD, FRCPC Director Comprehensive HIV Aging Initiative Chronic Viral Illness Service Senior Physician, Division
More informationConcept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA
Concept and General Objectives of the Conference: Prognosis Matters Andrew S. Levey, MD Tufts Medical Center Boston, MA General Objectives Topics to discuss What are the key outcomes of CKD? What progress
More informationCHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease
CHAPTER 2 Prevalence of Renal Replacement Therapy for End Stage Kidney Disease Summarising the number of prevalent renal replacement therapy patients in and, the prevalence rate per million population
More informationThe COLLaboration on AGEing (COLLAGE)
The COLLaboration on AGEing (COLLAGE) Professor D. William Molloy University College Cork, Ireland. The Lessons from Europe Seminar 23-09-15 Overview Exemplars within COLLAGE: 1. What is COLLAGE? 2. The
More informationA CONCEPT NOTE FOR PALLIATIVE CARE IN INDIA: USING THE EXAMPLE OF CHRONIC KIDNEY DISEASE
A CONCEPT NOTE FOR PALLIATIVE CARE IN INDIA: USING THE EXAMPLE OF CHRONIC KIDNEY DISEASE Dr.Mukesh Shete Consultant Nephrologist Director, Apex Kidney Care DEFINITION AND CONCEPTUAL FRAMEWORK OF SUPPORTIVE
More informationChapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report
Chapter 12 End Stage Kidney Disease in Indigenous Peoples of and Aotearoa/ 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, the rates and practice patterns for end-stage
More informationThe Long-term Prognosis of Delirium
The Long-term Prognosis of Jane McCusker, MD, DrPH, Professor, Epidemiology and Biostatistics, McGill University; Head, Clinical Epidemiology and Community Studies, St. Mary s Hospital, Montreal, QC. Nine
More informationThe Aging CKD Patient. Mark Unruh MD MS Professor and Chair of Medicine September 13, 2016 LSU Geriatric Nephrology Symposium
The Aging CKD Patient Mark Unruh MD MS Professor and Chair of Medicine September 13, 2016 LSU Geriatric Nephrology Symposium Mark Unruh MD MS Disclosure of relevant financial relationships I have no financial
More informationPALLIATIVE CARE IN GERIATRIC TRAUMA
PALLIATIVE CARE IN GERIATRIC TRAUMA Kathleen O Connell MD, MPH Assistant Professor of Surgery Director of Surgical Palliative Care Harborview Medical Center katmo@uw.edu DISCLOSURES NONE LEARNING OBJECTIVES
More informationThe Korean version of the FRAIL scale: clinical feasibility and validity of assessing the frailty status of Korean elderly
ORIGINAL ARTICLE Korean J Intern Med 2016;31:594-600 The Korean version of the FRAIL scale: clinical feasibility and validity of assessing the frailty status of Korean elderly Hee-Won Jung 1,2, Hyun-Jung
More informationCHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Stephen McDonald. Matthew Jose. Kylie Hurst INDIGENOUS 12-1
ANZDATA Registry 213 Report INDIGENOUS END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12 Stephen McDonald Matthew Jose Kylie Hurst 213 Annual Report - 36th Edition
More informationMacro- and Micronutrient Homeostasis in the Setting of Chronic Kidney Disease. T. Alp Ikizler, MD Vanderbilt University Medical Center
Macro- and Micronutrient Homeostasis in the Setting of Chronic Kidney Disease T. Alp Ikizler, MD Vanderbilt University Medical Center Nutrition and Chronic Kidney Disease What is the disease itself and
More informationChapter 1. Incidence of End Stage Kidney Disease. Contents:
Chapter 1 Incidence of End Stage Kidney Disease Contents: Incidence of End Stage Kidney Disease 1-1 Stock and Flow 1-2 Incident patients 1-3 Incident Rates 1-3 Late Referral 1-7 Co-Morbidities 1-9 Primary
More informationFIRST RENAL REPLACEMENT
FIRST RENAL REPLACEMENT THERAPY SELECTION IN DIABETIC PATIENTS Dr Cécile Couchoud (REIN registry, France) Davide Bolignano (ERBP, Italy) European Renal Best Practice Prof. Wim Van Biesen Chairman of ERBP
More informationNutritional Assessment in frail elderly. M. Secher, G.Abellan Van Kan, B.Vellas 1st December 2010 Firenze
Nutritional Assessment in frail elderly M. Secher, G.Abellan Van Kan, B.Vellas 1st December 2010 Firenze Frailty definition Undernutrition as part of the frailty syndrome Nutritional assessment in frail
More informationYou can sleep while I dialyze
You can sleep while I dialyze Nocturnal Peritoneal Dialysis Dr. Suneet Singh Medical Director, PD, VGH Division of Nephrology University of British Columbia Acknowledgements Melissa Etheridge You can sleep
More informationA comparison of treatment options for management of End Stage Kidney Disease in elderly patients: A systematic review protocol
A comparison of treatment options for management of End Stage Kidney Disease in elderly patients: A systematic review protocol Leanne Brown Master of Nursing Science (Nurse Practitioner) 1 Glenn Gardner
More informationKidney Transplant in the Elderly. Robert Santella, M.D., F.A.C.P.
Kidney Transplant in the Elderly! Robert Santella, M.D., F.A.C.P. Incident Rate of ESRD by Age Age 75+ 65-74 From US Renal Data System, 2012 Should there be an age limit? Various guidelines: Canadian,
More informationFrailty Assessment: Simplifying the Complex
Frailty Assessment: Simplifying the Complex Natalie Sanders, DO Internal Medicine, Geriatrics Rocky Mountain Geriatrics Conference 2017 U N I V E R S I T Y O F U T A H H E A L T H, 2 0 1 7 OBJECTIVES Define
More informationCardiovascular Diseases in CKD
1 Cardiovascular Diseases in CKD Hung-Chun Chen, MD, PhD. Kaohsiung Medical University Taiwan Society of Nephrology 1 2 High Prevalence of CVD in CKD & ESRD Foley RN et al, AJKD 1998; 32(suppl 3):S112-9
More informationUsing the Frail-NH and The Rapid Geriatric Assessment (RGA) in Long Term Care
Using the Frail-NH and The Rapid Geriatric Assessment (RGA) in Long Term Care Geriatric Workforce Decline in Geriatricians in the United States 1988 2030 Geriatricians 7,128 7,750 Geriatricians per older
More informationSurgery in Frail Elders. Emily Finlayson, MD, MS Department of Surgery University of California, San Francisco September, 2011
Surgery in Frail Elders Emily Finlayson, MD, MS Department of Surgery University of California, San Francisco September, 2011 What we re going to cover Mortality after surgery in the elderly Fact v Fantasy
More informationMeasure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes
Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationDelivering personalised care to end of life patients. Jane Naismith Nurse Consultant in Palliative care St Joseph s Hospice London
Delivering personalised care to end of life patients Jane Naismith Nurse Consultant in Palliative care St Joseph s Hospice London Over View This session will cover Supporting patients with long term conditions
More informationCare of the dying in End Stage Kidney Disease (ESKD) - Conservative. Elizabeth Josland Renal Supportive Care CNC St George Hospital
Care of the dying in End Stage Kidney Disease (ESKD) - Conservative Elizabeth Josland Renal Supportive Care CNC St George Hospital Introduction What does conservative management look like? How does the
More informationImproving End of Life Care for Older People
Improving End of Life Care for Older People Martin Vernon Consultant Geriatrician and Clinical Director British Geriatrics Society End of Life Care Champion Greater Manchester Integrated Care Clinical
More informationBack to dialysis after graft failure: Transplantectomy or not? Stop immunosuppression?
Back to dialysis after graft failure: Transplantectomy or not? Stop immunosuppression? Laurent WEEKERS CHU SartTilman Layout Introduction Epidemiology A note of caution on causality and bias Patient survival
More informationAetiology versus Prediction - correct for Confounding? Friedo Dekker ERA-EDTA Registry / LUMC
Aetiology versus Prediction - correct for Confounding? Friedo Dekker ERA-EDTA Registry / LUMC Aetiology Study effect of a risk factor on an outcome Consider potential confounding: other risk factor for
More informationDialysis in the elderly and frail patients. Angel LM de Francisco. Hospital Marqués de Valdecilla. Santander
Dialysis in the elderly and frail patients Angel LM de Francisco. Hospital Marqués de Valdecilla. Santander Incidence of RRT per million age related popula4on in 2014 by age group The incidence PMARP was
More informationNew perspec)ves on withdrawal from dialysis. Jennifer Chan, Phil Clayton, Stephen McDonald, John Agar, Ma?hew Jose
New perspec)ves on withdrawal from dialysis Jennifer Chan, Phil Clayton, Stephen McDonald, John Agar, Ma?hew Jose Figure 3.8 Cause of Death by RRT Modality Cause of Death 1-Jan-2009 to 31-Dec-2009 Australia
More informationFrailty. Nicholas Butler MD, MBA Department of Family Medicine University of Iowa
Frailty Nicholas Butler MD, MBA Department of Family Medicine University of Iowa Doris 84 yo female who comes into your clinic with her daughter. She complains of feeling increasingly fatigued and just
More information1. Reggie J. Divina, M.D. (1) 2. Fe S. Felicilda, M.D., DPBCN (1,2) 3. Rufino E. Chan, M.D. (1) 4. Luisito O. Llido, M.D.
82 TITLE: Nutritional status of hemodialysis patients in the Philippines: a cross sectional survey in four out- patient dialysis centers Submitted: January 10, 2010 Posted: August 30, 2010 AUTHOR(S) 1.
More informationNutrition to Support Symptom Management. Ann-Maree Randall Dietitian, RSC Nepean Hub
Nutrition to Support Symptom Management Ann-Maree Randall Dietitian, RSC Nepean Hub Malnutrition in RSC across NSW Malnutrition prevalence 48% conservative care 59% symptom support Change in nutritional
More information1/20/2013 CASE SOFTWARE & BOOKS REASSESSMENT OF ACUTE PHASE PROTEINS AS MARKERS OF MALNUTRITION POINTS TO PONDER FACTS ABOUT SERUM ALBUMIN
CASE SOFTWARE & BOOKS REASSESSMENT OF ACUTE PHASE PROTEINS AS MARKERS OF MALNUTRITION All rights reserved. No part of this presentation may be reproduced by any graphic, mechanical, photographic or electronic
More informationCHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Matthew Jose Stephen McDonald Leonie Excell
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG PEOPLES OF AUSTRALIA AND NEW ZEALAND Matthew Jose Stephen McDonald Leonie Excell INTRODUCTION Rates of end-stage kidney disease among the Peoples of and are substantially
More informationAbstract. Introduction. Volume 54 Number 4 Oct. - Dec., Philippine Journal of Internal Medicine. Original Paper
Philippine Journal of Internal Medicine Original Paper A Comparison Between Dialysis Versus Conservative Management as Modes of Treatment in the Management of Elderly Patients with End Stage Renal Disease:
More informationAge and treatment of kidney failure
REVIEW C URRENT OPINION Age and treatment of kidney failure Meghan J. Elliott a, Helen Tam-Tham b, Brenda R. Hemmelgarn a,b, for the Alberta Kidney Disease Network Purpose of review This review discusses
More informationISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world
ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world Nutrition in Kidney Disease: How to Apply Guidelines to Clinical Practice? T. Alp
More informationImproving Palliative Care Consultation in a Trauma ICU & Step- Down Unit Teresa Hobt-Bingham, MSN, RN, NE-BC
Improving Palliative Care Consultation in a Trauma ICU & Step- Down Unit Teresa Hobt-Bingham, MSN, RN, NE-BC Learning Objectives Define palliative care and frailty Understand the link between frailty and
More informationReadmissions and Palliative Care Breaking the Cycle
Readmissions and Palliative Care Breaking the Cycle Stephen Evans M.D. Physician Group Leader IPC of New York Medical, PC President and CEO of VIdex US, LLC Buffalo, New York Margaret Sayers MS, GNP COO
More informationChapter 15: Causes of Death on Renal Replacement Therapy
Chapter 15: Causes of Death on Renal Replacement Therapy Summary Cardiovascular disease is the most common cause of death in the renal population and is most evident in diabetics. Patients on renal replacement
More informationThe Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century?
The Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century? By: Baskar, WDHB, Renal Service Auckland New Zealand Presented at : 4 th International Conference on
More informationCARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017
CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017 RENEGOTIATING LIFE WITH CHRONIC KIDNEY DISEASE CONSTANTINI
More informationTO EAT OR NOT TO EAT DURING HEMODIALYSIS TREATMENT?
TO EAT OR NOT TO EAT DURING HEMODIALYSIS TREATMENT? Rana G. Rizk, PhD, MPH, LD Maastricht University, The Netherlands November, 2017 Learning objectives Review the evidence behind benefits and concerns
More informationSurvival of End Stage Renal Failure Patients with Cancer
Survival of End Stage Renal Failure Patients with Cancer Angela Webster Centre for Kidney Research, The Children s Hospital at Westmead Department of Renal Medicine, Westmead Hospital, NSW School of Public
More informationHEMODIALFILTRATION LITERATURE REVIEW AND PRACTICE CONSIDERATIONS 1.0 PRACTICE CONSIDERATIONS 2.0 CURRENT LITERATURE REVIEW
HEMODIALFILTRATION LITERATURE REVIEW AND PRACTICE CONSIDERATIONS This document was prepared at the request of the BC Hemodialysis Committee to provide a brief overview of the literature and to identify
More informationFrailty: Challenges and Possible Solutions
Frailty: Challenges and Possible Solutions EMA Workshop: Ensuring safe and effective medicines for an ageing population Niccolò Marchionni Professor of Geriatrics University of Florence, Italy 22-23 March
More informationOutcomes in GEM models of geriatric care: How do we measure success? Disclosure. Objectives. Geriatric Grand Rounds
Geriatric Grand Rounds Tuesday, October 7, 2008 12:00 noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital Outcomes in GEM models of geriatric care: How do we measure success? In keeping with
More informationThe Frail and At-Risk Critically Ill: Screening and Outcomes
The Frail and At-Risk Critically Ill: Screening and Outcomes Sean M Bagshaw, MD, MSc Department of Critical Care Medicine, University of Alberta, Edmonton, Canada CCCF, Toronto, Canada October 2, 2017
More informationOverweight and Obesity in Older Persons: Impact Upon Health and Mortality Outcomes
Overweight and Obesity in Older Persons: Impact Upon Health and Mortality Outcomes Gordon L Jensen, MD, PhD Senior Associate Dean for Research Professor of Medicine and Nutrition Objectives Health outcomes
More information